Terray Therapeutics today unveiled the latest EMMI prediction model, a universal potency model that outperforms the industry: ...

A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...

Piper Sandler Virtual Novel Targets in Immunology Symposium February 12, 2026 5:00 PM ESTCompany ParticipantsPaul Burton - Senior VP ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership ...

Background Drug exposure has been reported in association with Takotsubo syndrome, but the breadth and relative strength of ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q4 2025 Earnings Conference Call. [Operator ...

Detailed price information for Shattuck Labs Inc (STTK-Q) from The Globe and Mail including charting and trades.

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update First Commercial Sales of REDEMPLO® Following its approval in November 2025, Arrowhead Pharmaceuticals, Inc.

Jharkhand Board Class 12 Chemistry Question Paper 2026: The Jharkhand Academic Council (JAC) successfully conducted the Class 12 Chemistry board examination on 13 February 2026 from 2:00 PM to 5:15 PM ...